United Kingdom Biomarkers Market Size, Share Report 2035
The biomarkers market in the United Kingdom is growing steadily because of the increasing incidence of chronic and oncological disorders, the aging population, and the growing awareness of early and precision diagnostics. There has been considerable improvement in diagnostic accuracy and clinical efficiency because of the advancements in the fields of genomics, proteomics, AI analytics, and digital health platforms.